Introduction: Resistant bacterial infections following brain and spine surgery and spontaneous mucormycosis with central nervous system (CNS) involvement represent a serious treatment challenge and more efficient therapeutic approaches ought to be considered. Hyperbaric oxygen treatment (HBOT) has shown promise as a complementary therapy. This case series evaluated whether HBOT contributed to infection resolution in seven patients with refractory CNS infectious conditions. Methods: Clinical results for seven patients referred for HBOT between 2010 to 2018 to treat refractory postoperative brain and spine infections or spontaneously developing mucormycosis were retrospectively analysed. The patients’ clinical files and follow-up consultations were reviewed to assess evolution and outcome. Results: Seven patients were referred with a median age of 56 years. The median follow-up was 20 months. Four patients had postoperative infections and three had rhino-orbital-cerebral mucormycosis (ROCM). HBOT was used as an adjunctive treatment to antimicrobial therapy in all patients. Prior to HBOT, all patients had undergone an average of four operations due to infection refractoriness and had completed an average of five months of antimicrobial therapy. After HBOT, infection resolution was obtained in six patients without additional operations, while one patient with ROCM stopped HBOT after the third session due to intolerance. Three patients stopped antimicrobial therapy while four were maintained on prophylactic treatment. Conclusions: Infection resolution was reached in the six patients that completed HBOT as prescribed. HBOT may serve as an effective complementary treatment in CNS refractory postoperative and spontaneous infections.
Introduction: Lumbar disc herniation (LDH) is a prevalent condition that can cause radiculopathy and leg pain. Full-endoscopic lumbar discectomy (FELD) has emerged as a minimally invasive alternative to microdiscectomy, offering similar clinical efficacy with potentially reduced recovery times. Degenerative disc disease (DDD) is frequently observed in patients undergoing surgery, yet its influence on surgical early outcomes of FELD remains unclear. Methods: This prospective study included 91 patients who underwent FELD for single-level LDH between January 2022 and March 2024. Patients were classified in two groups based on Pfirrmann grade: grade inferior to 4 (Group 1) and grade 4 or 5 (Group 2). Clinical outcomes were assessed using the Numeric Rating Scale (NRS) for back and leg pain preoperatively and at 2, 14, 30, and 90 days postoperatively, and the Oswestry Disability Index (ODI) preoperatively and at 30 and 90 days postoperatively. Results: Among the 91 patients, 89% had advanced disc degeneration (Pfirrmann grade 4 or 5). Preoperatively, Group 1 (all Pfirrmann 3) had significantly higher back pain (NRS 8.2 vs. 5.2, P < 0.01), while Group 2 had a greater difference between leg and back pain ( P = 0.041). Postoperatively, both groups experienced significant pain relief, but Group 1 showed superior back pain improvement across all time points. No significant differences were observed in ODI scores or leg pain improvement. Discussion: Patients with moderate disc degeneration (Pfirrmann grade 3) exhibited greater preoperative back pain but experienced superior back pain relief after FELD compared with those with advanced degeneration (Pfirrmann grade 4 or 5).